Preview

Rational Pharmacotherapy in Cardiology

Advanced search

RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME

https://doi.org/10.20996/1819-6446-2018-14-3-344-349

Full Text:

Abstract

Aim. To study the erythrocyte electric charge (EEC) in patients with metabolic syndrome (MS).

Material and methods. 112 patients (mean age 61.4±7.2 years) with MS (average duration of MS 8.7±5.2 years) were examined. Control group consisted of healthy volunteers (n=25) of similar age. The level of EEC was detected by the method of adsorption of a positive cationic dye (cationic blue O) on the surface of the erythrocyte plasma membrane up to the complete neutralization of their negative charge, followed by photometry of the solution and calculation of the number of charges on the erythrocyte cell surface. The results of the study were processed by Statistica 10.0 software.

Results. Hypertension was found in 73% of patients with MS, hyperglycemia – in 39%, diabetes – in 36%, dyslipidemia – in 80% of patients. The EEC in MS patients (1.59±0.05×107) was lower than this in the control group (1.65±0.03×107; p<0.05). With MS duration more than 5 years, the EEC was significantly lower in comparison with control group (p<0.05). In patients with obesity II-III degrees as well as dyslipidemia the EEC values were significantly lower vs control group (p<0.05). In patients with MS, a significant negative correlation of EEC with total cholesterol (r=-0.51, p<0.05) and triglycerides (r=-0.51, p<0.05) levels were revealed.

Conclusion. In patients with MS with increase in the MS duration, degree of obesity and lipid metabolism disorders, significantly lower values of EEC were observed. 

About the Authors

V. I. Podzolkov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Professor, Head of Chair of Faculty Therapy №2,

Trubetskaya ul. 8/2, Moscow, 119991



T. V. Koroleva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Professor, Chair of Faculty Therapy №2,

Trubetskaya ul. 8/2, Moscow, 119991



A. E. Bragina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Professor, Chair of Faculty Therapy №2,

Trubetskaya ul. 8/2, Moscow, 119991



M. G. Kudryavtseva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, Postgraduate Student, Chair of Faculty Therapy №2,

Trubetskaya ul. 8/2, Moscow, 119991



G. I. Bragina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Associate Professor, Chair of Polyclinic Therapy, 

Trubetskaya ul. 8/2, Moscow, 119991



M. V. Pisarev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Associate Professor, Chair of Faculty Therapy №2,

Trubetskaya ul. 8/2, Moscow, 119991



References

1. National guidelines on the diagnosis and treatment of the metabolic syndrome (2009). [cited 19 Jun, 2018]. Available at: https:// www.scardio.ru/Fcontent/Fimages/Frecommendation/Fnacionalnye_ rekomendacii_po_diagnostike_i_lecheniyu_metabolicheskogo_sindroma.pdf. (In Russ.) [Национальные рекомендации по диагностике и лечению метаболического синдрома (2009). [Цитировано 19.06.2018]. Доступно на: https:// www.scardio.ru/Fcontent/Fimages/Frecommendation/ Fnacionalnye_rekomendacii_po_diagnostike_i_lecheniyu_metabolicheskogo_sindroma.pdf].

2. Podzolkov V.I., Bragina A.E., Murashko N.A. The level of stable metabolites of nitric oxide in patients with essential hypertension with obesity and hyperleptinemia. Kardiologiia. 2016;7(56):14-9. (In Russ.) [Подзолков В.И, Брагина А.Е., Мурашко Н.А. Уровень стабильных метаболитов оксида азота у больных эссенциальной гипертензией с ожирением и гиперлептинемией. Кардиология. 2016;7(56):14-9]. doi: 10.18565/cardio.2016.6.14-19.

3. Ahmatov V.Ju., Osipov M.V., Krivozhihina L.V. To the mechanism of erythrocyte dysfunction in patients with chronic renal failure who are on hemodialysis. Nefrologija i Dializ. 2007;9(3):276-77. (In Russ.) [Ахматов В.Ю., Осипов М.В., Кривожихина Л.В. К механизму дисфункции эритроцитов у больных хронической почечной недостаточностью, находящихся на гемодиализе. Нефрология и Диализ. 2007;9(3):276-77].

4. Martynova T.A., Maksimov N.I., Nazipova T.Ju. Possibilities of the method of microelectrophoresis of erythrocytes in the diagnosis of acute coronary syndrome. Prakticheskaja Medicina. 2015;3(88):33- 5. (In Russ.) [Мартынова Т.А., Максимов Н.И., Назипова Т.Ю. Возможности метода микроэлектрофореза эритроцитов в диагностике острого коронарного синдрома Практическая Медицина. 2015;3(88):33-5].

5. Badaljan K.R., Vasilenko I.A., Fedin A.I. Biophysical properties of peripheral blood erythrocytes in patients with chronic cerebral ischemia. Lechebnoe Delo. 2015;1:84-90. (In Russ.) [Бадалян К.Р., Василенко И.А., Федин А.И. Биофизические свойства эритроцитов периферической крови у больных с хронической ишемией мозга. Лечебное Дело. 2015;1:84-90].

6. Sokolov E.I., Zykova A.A., Sushchik V.V., Goncharov I.N. Blood Viscosity in Patients With Ischemic Heart Diseases. Kardiologiia. 2014;54(3):9-14. (In Russ.) [Соколов Е.И., Зыкова А.А., Сущик В.В., Гончаров И.Н. Вязкость крови у больных ишемической болезнью сердца. Кардиология. 2014;3:9-14].

7. Podzolkov V.I., Bulatov V.A. Microcirculation state in arterial hypertension. In book: Podzolkov VI. Arterial hypertension. Moscow: MIA; 2016. P. 45-50. (In Russ.) [Подзолков В.И., Булатов В.А. Состояние микроциркуляции при артериальной гипертензии. В кн.: Подзолков В.И. Артериальная гипертензия. Москва: МИА;2016. C. 45-50].

8. National guidelines on the diagnosis and treatment of the metabolic syndrome (2013). [cited 19 Jun, 2018]. Available at: www.gipertonik.ru/files/recommendation/Recommendations_metabolic_syndrome.doc. (In Russ.) [Национальные рекомендации по диагностике и лечению метаболического синдрома (2013). [Цитировано 19.06.2018]. Доступно на: www.gipertonik.ru/files/ recommendation/Recommendations_metabolic_syndrome.doc].

9. Gyawali P., Richards R.S., Hughes D.L., Tinley P. Erythrocyte aggregation and metabolic syndrome Clin Hemorheol Microcirc. 2014;57(1):73-83. doi: 10.3233/CH-131792.

10. Surikova T.P. The study of the dependence of the erythrocyte charge in patients with diabetes mellitus, depending on the severity of its course. Astrahanskij Medicinskij Zhurnal. 2012;2(7):206-7. (In Russ.) [Сурикова Т.П. Изучение зависимости заряда эритроцитов у больных сахарным диабетом в зависимости от тяжести его протекания. Астраханский Медицинский Журнал. 2012;2(7):206-7].

11. Gyawali P., Richards R.S., Bwititi P., Nwose E.U. The association of dyslipidemia with erythrocyte aggregation. Clinical Lipidology. 2015;2:129-35. doi: 10.2217/clp.15.3.

12. Brun J.F., Varlet-Marie E., Fedou C., et al. Are metabolically healthy obese patients also hemorheologically healthy? Clin Hemorheol Microcirc. 2015;61(1):39-46. doi: 10.3233/CH-141868.

13. Sashenkov S.L., Alacheva L.V., Tishevskaja N.V. The effect of various pharmacological preparations on the surface charge of the erythrocyte membrane. Vestnik Juzhno-Ural'skogo Gosudarstvennogo Universiteta. 2011; 7(244):101-4. (In Russ.) [Сашенков С.Л., Алачева Л.В., Тишевская Н.В. Влияние различных фармакологических препаратов на поверхностный заряд мембраны эритроцитов. Вестник Южно-Уральского Государственного Университета. 2011;7(244):101-4].

14. Gyawali P., Richards R.S., Bwititi P.T. et al. Association of abnormal erythrocyte morphology with oxidative stress and inflammation in metabolic syndrome. Blood Cells Mol Dis. 2015;54(4):360-3. doi: 10.1016/j.bcmd.2015.01.005.

15. Kuznecova Je.Je., Gorohova V.G., Korjakina L.B., Babushkina I.V. Some aspects of the evaluation of structural and functional changes in the erythrocyte membrane in cardiovascular pathology. Bjulleten' VSNC SO RAMN. 2012;4(86)part 1:236-40. (In Russ.) [Кузнецова Э.Э., Горохова В.Г., Корякина Л.Б., Бабушкина И.В. Некоторые аспекты оценки структурно-функциональных изменений в мембране эритроцитов при сердечно-сосудистой патологии. Бюллетень ВСНЦ СО РАМН. 2012;4(86) часть 1:236-40].

16. Choi H.N., Yim J.E. Effects of Erythrocyte Membrane Polyunsaturated Fatty Acids in Overweight, Obese, and Morbidly Obese Korean Women. Journal of Cancer prevention. 2017;22(3):182-8. doi: 10.15430/JCP.2017.22.3.182.

17. Rahamon S.K., Fabian U.A., Charles-Davies M.A. et al. Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome. African health Sciences. 2017;17(2):453-62. doi: 10.4314/ahs.v17i2.20.

18. Olszewska-Banaszczyk M., Jackowska P., Gorzelak-Pabiś P., et al. Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease. Pharmacol Rep. 2017;20;70(2):258-62. doi: 10.1016/j.pharep.2017.11.004

19. Mahendra J.V., Kumar S.D., Anuradha T.S. et al. Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy. J Clin Diagn Res. 2015;9(1):BC18-21. doi: 10.7860/JCDR/2015/10712.5449.

20. Ding L., Zhang C., Zhang G.A. et al. new insight into the role of plasma fibrinogen in the development of metabolic syndrome from a prospective cohort study in urban Han Chinese population. Diabetology and Metabolic Syndrome. 2015;7:110. doi: 10.1186/s13098-015-0103-7.

21. Gyawali P., Richards R.S., Tinley P. et al. Hemorheological parameters better classify metabolic syndrome than novel cardiovascular risk factors and peripheral vascular disease marker. Clin Hemorheol Microcirc. 2016;4:64(1):1-5. doi:10.3233/CH-152033.


For citation:


Podzolkov V.I., Koroleva T.V., Bragina A.E., Kudryavtseva M.G., Bragina G.I., Pisarev M.V. RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME. Rational Pharmacotherapy in Cardiology. 2018;14(3):344-349. (In Russ.) https://doi.org/10.20996/1819-6446-2018-14-3-344-349

Views: 122


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)